David Michael Clark's Insider Trades & SAST Disclosures
David Michael Clark's most recent trade in Amicus Therapeutics Inc was a trade of 52,338 Common Stock done . Disclosure was reported to the exchange on Feb. 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David Michael Clark.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 52,338 | 368,854 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.57 per share. | 11 Feb 2025 | 20,593 | 348,261 (0%) | 0% | 9.6 | 197,075 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 125,430 | 125,430 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 69,228 | 331,195 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.41 per share. | 02 Jan 2025 | 11,987 | 319,208 (0%) | 0% | 9.4 | 112,798 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.31 per share. | 02 Jan 2025 | 5,381 | 261,967 (0%) | 0% | 9.3 | 50,097 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.41 per share. | 02 Jan 2025 | 2,692 | 316,516 (0%) | 0% | 9.4 | 25,332 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 15 Feb 2024 | 4,427 | 253,664 (0%) | 0% | 14 | 61,978 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 13,684 | 280,389 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Michael David Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.65 per share. | 09 Jan 2024 | 8,614 | 258,091 (0%) | 0% | 13.6 | 117,581 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.65 per share. | 09 Jan 2024 | 8,614 | 271,775 (0%) | 0% | 13.6 | 117,581 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 08 Jan 2024 | 8,726 | 268,089 (0%) | 0% | 14 | 122,164 | Common Stock |
| Amicus Therapeutics Inc | Michael David Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 08 Jan 2024 | 1,384 | 266,705 (0%) | 0% | 14 | 19,376 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.44 per share. | 04 Jan 2024 | 2,692 | 276,815 (0%) | 0% | 13.4 | 36,180 | Common Stock |
| Amicus Therapeutics Inc | Clark David Michael | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 83,221 | 83,221 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Clark David Michael | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 48,209 | 297,488 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Clark Michael David | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.53 per share. | 02 Jan 2024 | 11,650 | 279,507 (0%) | 0% | 13.5 | 157,625 | Common Stock |
| Amicus Therapeutics Inc | Clark Michael David | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.24 per share. | 02 Jan 2024 | 6,331 | 291,157 (0%) | 0% | 14.2 | 90,153 | Common Stock |
| Amicus Therapeutics Inc | Clark Michael David | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 8,212 | 249,279 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 13.50 per share. | 18 Jan 2023 | 7,382 | 241,067 (0%) | 0% | 13.5 | 99,657 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 47,621 | 267,187 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.02 per share. | 11 Jan 2023 | 18,738 | 248,449 (0%) | 0% | 12.0 | 225,231 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 11.87 per share. | 04 Jan 2023 | 21,507 | 219,566 (0%) | 0% | 11.9 | 255,346 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.03 per share. | 04 Jan 2023 | 2,692 | 241,073 (0%) | 0% | 12.0 | 32,385 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 105,388 | 105,388 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 59,372 | 249,575 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.21 per share. | 02 Jan 2023 | 11,336 | 198,696 (0%) | 0% | 12.2 | 138,413 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 02 Jan 2023 | 8,493 | 190,203 (0%) | 0% | 12.0 | 102,176 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.93 per share. | 02 Jan 2023 | 5,810 | 243,765 (0%) | 0% | 11.9 | 69,313 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.40 per share. | 09 Oct 2022 | 5,510 | 210,032 (0%) | 0% | 10.4 | 57,304 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 12.50 per share. | 05 Aug 2022 | 11,322 | 215,542 (0%) | 0% | 12.5 | 141,525 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 108,266 | 108,266 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 59,071 | 207,313 (0%) | 0% | - | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 32,235 | 239,548 (0%) | 0% | - | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.53 per share. | 14 Jan 2022 | 12,684 | 226,864 (0%) | 0% | 10.5 | 133,563 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.51 per share. | 09 Oct 2021 | 5,510 | 168,879 (0%) | 0% | 11.5 | 63,420 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2021 | 16,883 | 174,389 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2021 | 44,076 | 44,076 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2021 | 27,369 | 157,506 (0%) | 0% | - | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.09 per share. | 02 Jan 2021 | 10,974 | 130,137 (0%) | 0% | 23.1 | 253,390 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.12 per share. | 09 Oct 2020 | 5,510 | 141,111 (0%) | 0% | 15.1 | 83,284 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges